YUSIMRY(CF) 40 MG/0.8 ML PEN

adalimumab-aqvh
$604.1530per ML

Strength

40 mg/.8mL

NDC

71288081581

Classification

Brand Biologic

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

10/29/2025

Active Ingredients

ADALIMUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA761216

On Market Since

7/1/2023

Pharmacological Classes

Antibodies
Monoclonal
Tumor Necrosis Factor Blocker
Tumor Necrosis Factor Receptor Blocking Activity

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

N/A

3Y

N/A

5Y

N/A

All

N/A